22q11.2 deletion syndrome: DiGeorge, velocardiofacial, and conotruncal anomaly face syndromes

Current Opinion in Pediatrics

Volumn 13, Issue 5, 2001, Pages 465-472

  Cuneo, Bettina F ^a,b  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b Heart Institute for Children   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOSOMAL DOMINANT DISORDER; CHROMOSOME 22Q; CONGENITAL MALFORMATION; CONOTRUNCAL ANOMALY FACE SYNDROME; DIGEORGE SYNDROME; DISEASE ASSOCIATION; FACE DYSMORPHIA; FLUORESCENCE IN SITU HYBRIDIZATION; GENE DELETION; GENE EXPRESSION; GENE TRANSLOCATION; GENETIC PREDISPOSITION; GENOTYPE; HEART DISEASE; HEREDITY; HUMAN; HYPOCALCEMIA; HYPOPARATHYROIDISM; IMMUNE DEFICIENCY; LEARNING DISORDER; PALATE MALFORMATION; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SPEECH DISORDER; T LYMPHOCYTE; VELOCARDIOFACIAL SYNDROME;

CHILD; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 22; DIGEORGE SYNDROME; FACIES; HUMANS; HYPOCALCEMIA; HYPOPARATHYROIDISM; IN SITU HYBRIDIZATION, FLUORESCENCE; LEARNING DISORDERS; PHENOTYPE; SYNDROME; VELOPHARYNGEAL INSUFFICIENCY;

EID: 0035196538     PISSN: 10408703     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008480-200110000-00014     Document Type: Review

References (71)

1. Autosomal dominant "Opitz" GBB syndrome due to a 22q11 deletion
2. Seven new cases of Cayler cardiofacial syndrome with 22q11.2 deletion, including a familial case
3. Spectrum of clinical features associated with interstitial chromosome 22q11 deletions: A European collaborative study
4. Syndrome of the month: DiGeorge syndrome: Part of CATCH 22
5. Closing time for CATCH 22
6. Prevalence of 22q11 microdeletions in DGS and VCFS: Implications for genetic counseling and prenatal diagnosis
7. The annual incidence of DiGeorge/velocardiofacial syndrome
8. The Philadelphia story: The 22q11.2 deletion: Report on 250 patients
9. UFD1L, a developmentally expressed ubiquitination gene, is deleted in CATCH 22 syndrome
10. A molecular pathway revealing a genetic basis for human cardiac and craniofacial defects
11. Congenital heart disease in mice deficient for the DiGeorge syndrome region
12. TBX1 is for cardiovascular defects in velo-cardio-facial/DiGeorge syndrome
13. Patients with a 22q11.2 deletion with no overlap of the minimal DiGeorge syndrome critical region (MDGCR)
14. Deletion mapping of 22q11 in CATCH 22 syndrome: Identification of a second critical region
15. Atypical deletions suggest five 22q11.2 critical regions related to the DiGeorge/velo-cardio-facial syndrome
16. DiGeorge syndrome: A historical review of clinical and cytogenetic features
17. A common region of 10p deleted in DiGeorge and velocardiofacial syndromes
18. Partial DiGeorge syndrome in two patients with a 10p rearrangement
19. Characterization of 10p deletions suggests two non-overlapping regions contribute to the DiGeorge syndrome phenotype
20. DiGeorge anomaly and chromosome 10p deletions: One or two loci?
21. An HDR (hypoparathyroidism, deafness, renal dysplasia) syndrome locus maps distal to the DiGeorge syndrome region on 10p13/14
22. The phenotypic spectrum of the 10p deletion syndrome versus the classical DiGeorge syndrome
23. HDR syndrome (hypoparathyroidism, sensorineural deafness, renal dysplasia associated with del (10)(p13))
24. Dual-probe fluorescence in situ hybridization assay for detecting deletions associated with VCFS/DiGeorge syndrome I and DiGeorge syndrome II loci
25. DiGeorge anomaly with renal agenesis in infants of mothers with diabetes
26. The DiGeorge syndrome and fetal alcohol syndrome
27. Retinoic acid embryopathy
28. PCR assay for screening patients at risk for 22q11 deletion
29. Frequency of 22q11 deletion with conotruncal defects
30. Incidence and significance of 22q11.2 hemizygosity in patients with interrupted aortic arch
31. A search for chromosome 22q11.2 deletions in a series of 176 consecutively catheterized patients with congenital heart disease: No evidence for deletions in non-syndromic patients
32. Anatomic patterns of conotruncal defects associated with deletion 22q11
33. Epidemiology of congenital heart disease: The Baltimore Washington infant study 1981-1989
34. Velocardiofacial syndrome: Incidence of immune cytopenias
35. Increased prevalence of immunoglobulin A deficiency in patients with the chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome)
36. Humoral immunity in DiGeorge syndrome
37. The frequency and severity of immunodeficiency in chromosome 22q11.2 deletion syndromes (DiGeorge syndrome/velocardiofacial syndrome)
38. Clinical and immunologic spectrum of the DiGeorge syndrome
39. Thymic function after hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency
40. Echocardiographic identification of thymic hypoplasia in tetralogy of Fallot/tetralogy pulmonary atresia
41. Echocardiographic identification of thymic tissue in neonates with congenital heart disease
42. JRA-like polyarthritis in chromosome 22q11.2 deletion syndrome (DiGeorge anomalad/velo-cardiofacial syndrome/conotruncal anomaly face syndrome)
43. Juvenile rheumatoid arthritis in velo-cardio-facial syndrome
44. Clinical characteristics of children with hypoparathyroidism due to 22q11.2 microdeletion
45. Prediction of persistent immunodeficiency in the DiGeorge anomaly
46. The DiGeorge syndrome. I. Clinical evaluation and course of partial and complete forms of the syndrome
47. Transient congenital hypoparathyroidism: Resolution and recurrence in chromosome 22q11 deletion
48. Hypoparathyroidism as the major manifestation in two patients with 22q11 deletions
49. Unmasking of hypoparathyroidism in familial partial DiGeorge syndrome by challenge with disodium edetate
50. Latent hypoparathyroidism in children with conotruncal cardiac defects
51. Evolution of latent hypoparathyroidism in familial 22q11 deletion syndrome
52. Auxological evaluation in patients with DiGeorge velocardiofacial syndrome (deletion 22q11.2 syndrome)
53. Velo-cardio-facial syndrome: A review of 120 patients
54. The velo-cardio-facial syndrome: A clinical and genetic analysis
55. DiGeorge syndrome: Part of CATCH 22
56. Deletions and microdeletions of 22q11.2 in velo-cardio-facial syndrome
57. Oral findings in DiGeorge syndrome
58. Are 22q11 chromosomal deletions a major cause of isolated cleft palate?
59. Retrospective analysis of feeding and speech disorders in 50 patients with velocardiofacial syndrome
60. Dysphagia in children with a 22q11.2 deletion: Unusual pattern found on modified barium swallow
61. Communication issues in 22q11.2 deletion syndrome: Children at risk
62. A new syndrome involving cleft palate, cardiac anomalies, typical facies and learning disabilities: Velocardio-facial syndrome
63. Behavioral phenotypes
64. Intelligence and psychosocial adjustment in velo-cardio-facial syndrome: A study of 37 infants and children with VCFS
65. Velocardiofacial (Shprintzen) syndrome: An important syndrome for the dysmorphologist to recognize
66. The behavioral phenotype in velocardio-facial syndrome (VCFS): From infancy to adolescence
67. Characteristic cognitive profile in patients with a 22q11.2 deletion: Verbal IQ exceeds nonverbal IQ
68. Velocardiofacial syndrome: Learning difficulties and intervention
69. Neuropsychological profile of children and adolescents with the 22q11.2 microdeletion
70. Late-onset psychosis in the velo-cardio-facial syndrome
71. Schizophrenia susceptibility associated with interstitial deletions of chromosome 22q11